Valuation: Inogen, Inc.

Market Cap 149M 128M 121M 110M 206M 14.24B 209M 1.42B 555M 7.12B 558M 546M 23.72B P/E 2026 *
-7.4x
P/E 2027 * -12x
Enterprise Value 149M 128M 121M 110M 206M 14.24B 209M 1.42B 555M 7.12B 558M 546M 23.72B EV / Sales 2026 *
0.42x
EV / Sales 2027 * 0.4x
Free-Float
87.11%
Yield 2026 *
-
Yield 2027 * -
1 day-1.93%
1 week-5.08%
Current month-13.18%
1 month-14.76%
3 months-11.11%
6 months-3.95%
Current year-16.67%
1 week 5.57
Extreme 5.57
5.9
1 month 5.57
Extreme 5.57
6.93
Current year 5.34
Extreme 5.3401
7.67
1 year 5.34
Extreme 5.3401
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
61.78
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-09
Director of Finance/CFO 48 2026-04-05
Chief Operating Officer 56 2026-07-05
Director TitleAgeSince
Director/Board Member 66 2014-08-05
Chairman 65 2021-12-28
Director/Board Member 59 2022-03-21
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Free

Chief Operating Officer

-130,000 0.4802%
7/1/26 Sell

Head of Human Resources

-10,938 0.0404%
2/27/26 Fiscal year

Executive/Senior Manager

52,032 0.1917%
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-5.08%-25.83%-10.97% 152M
+2.09%+2.70%-13.50%+8.65% 191B
+1.64%+1.55%-0.78%+12.97% 116B
+1.16%-5.31%+8.88%+75.24% 59.64B
-2.68%-1.60%+29.69%+62.77% 55.42B
-0.72%-0.35%-7.30%-33.95% 49.6B
+0.95%+0.08%+10.86%-15.51% 33.49B
-2.18%-2.63% - - 30.6B
-6.42%-7.23%-13.48%+17.04% 24.25B
-0.01%-1.36%+42.58%-10.62% 24.39B
Average -0.81%-0.81%+3.46%+11.73% 58.45B
Weighted average by Cap. +0.48%+0.55%+0.39%+16.38%

Financials

2026 *2027 *
Net sales 356M 308M 290M 263M 495M 34.16B 502M 3.4B 1.33B 17.08B 1.34B 1.31B 56.9B 373M 322M 303M 276M 518M 35.75B 526M 3.56B 1.39B 17.88B 1.4B 1.37B 59.56B
Net income -20.6M -17.79M -16.74M -15.21M -28.62M -1.97B -29.04M -196M -76.96M -987M -77.34M -75.66M -3.29B -13M -11.23M -10.56M -9.6M -18.06M -1.25B -18.32M -124M -48.56M -623M -48.81M -47.75M -2.08B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
26-08-18 US$5.600 -1.93% 242,607
26-08-17 US$5.710 -0.70% 265,961
26-08-14 US$5.750 -1.03% 204,693
26-08-13 US$5.810 0.00% 166,075
26-08-12 US$5.810 -1.53% 239,489
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.600USD
Average target price
12.67USD
Spread / Average Target
+126.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock